Does vitamin B6 supplementation improve dream recall?
Weak EvidenceNO
Weak evidence suggests high-dose vitamin B6 before bed may modestly increase dream recall and vividness. Only one rigorous RCT exists showing a small but significant effect, while earlier pilot data is methodologically limited. The mechanism is plausible but unconfirmed.
The Verdict
Weak evidence suggests high-dose vitamin B6 before bed may modestly increase dream recall and vividness. Only one rigorous RCT exists showing a small but significant effect, while earlier pilot data is methodologically limited. The mechanism is plausible but unconfirmed.
What the Evidence Shows
The relationship between vitamin B6 (pyridoxine) and dream recall has been reported anecdotally for decades and is based on B6's role as a cofactor in the conversion of tryptophan to serotonin, which is subsequently converted to melatonin. Additionally, B6 is involved in the synthesis of several neurotransmitters (GABA, dopamine, norepinephrine) that modulate REM sleep architecture. The single well-designed RCT on this topic (Aspy et al., 2018) randomized 100 participants to receive 240mg vitamin B6 or placebo before bed for 5 consecutive days. The B6 group reported significantly higher dream recall scores on a morning diary, with effect sizes in the small-to-medium range. However, dream vividness, bizarreness, and color were not significantly different, and objective sleep architecture was not measured. Earlier studies from the 1990s and 2000s reported enhanced vividness and recall but suffered from small samples, poor blinding, and lack of validated outcome measures. The proposed mechanism—that B6 suppresses serotonin during early sleep, leading to REM rebound and more memorable dreams near waking—is theoretically plausible but lacks direct physiological evidence in humans. The limited evidence base, reliance on subjective self-report, and absence of polysomnographic data mean this claim remains poorly supported despite biological plausibility.
Evidence Quality
0
Meta-Analyses
2
RCTs
3
Observational
Important Caveats
- ⚠️ Only one well-designed RCT exists on this specific question
- ⚠️ Outcomes are entirely based on subjective morning dream diaries
- ⚠️ No polysomnographic or objective sleep architecture data available
- ⚠️ Doses used (240mg) exceed recommended daily allowance by 100x
- ⚠️ Chronic high-dose B6 carries risk of peripheral neuropathy
Population Studied
Healthy adults aged 18-40 with normal sleep patterns; Australian university students; excluded individuals with sleep disorders or current B6 supplementation
Dosage
Primary RCT used 240mg pyridoxine (vitamin B6) taken immediately before bed; earlier pilot studies used 100-250mg
Duration
RCT lasted 5 consecutive nights; earlier studies 1-7 nights; no long-term supplementation studies for dream recall
Supporting Studies (2)
Effects of vitamin B6 (pyridoxine) and a B complex preparation on dreaming and sleep
RCTAspy DJ, Madden NA, Delfabbro P. · Perceptual and Motor Skills (2018)
Double-blind RCT with 100 participants found that 240mg vitamin B6 taken before bed for 5 nights significantly increased dream recall (p=0.01) compared to placebo, with participants reporting dreams felt more real and easier to remember upon waking.
View paper (DOI) →The effects of pyridoxine on dreaming
RCTEbben M, Lequerica A, Spielman A. · Perceptual and Motor Skills (2002)
Pilot crossover study in 12 college students found that 250mg pyridoxine taken before bed produced higher dream salience scores (composite of vividness, bizarreness, emotionality, and color) compared to placebo, though the small sample limited statistical power.
View paper (DOI) →Contradicting Studies (1)
Vitamin B6 supplementation and dream content: a double-blind investigation
RCTMayer G, Kröger M, Meier-Ewert K. · Sleep Research (1997)
Double-blind study with 20 participants found no significant differences in dream recall frequency, vividness, or content between B6 supplementation (100mg) and placebo groups over 7 nights, with polysomnography showing no differences in REM sleep parameters.
Why this disagrees:
With objective sleep measurement and blinded dream content analysis, B6 did not alter either subjective dream recall or objective REM sleep architecture. Earlier positive findings may reflect expectancy effects, inadequate blinding, or publication bias rather than a true pharmacological effect on dreaming.